230 related articles for article (PubMed ID: 26228776)
1. Chitosan coatings to control release and target tissues for therapeutic delivery.
Jennings JA; Wells CM; McGraw GS; Velasquez Pulgarin DA; Whitaker MD; Pruitt RL; Bumgardner JD
Ther Deliv; 2015 Jul; 6(7):855-71. PubMed ID: 26228776
[TBL] [Abstract][Full Text] [Related]
2. Controlling the functional performance of emulsion-based delivery systems using multi-component biopolymer coatings.
Li Y; Hu M; Xiao H; Du Y; Decker EA; McClements DJ
Eur J Pharm Biopharm; 2010 Sep; 76(1):38-47. PubMed ID: 20470883
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
Cai J; Zhang Y; Du W; Nan K
J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
[No Abstract] [Full Text] [Related]
4. Recent advances in chitosan films for controlled release of drugs.
Mengatto LN; Helbling IM; Luna JA
Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):156-70. PubMed ID: 22436027
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.
Mazzarino L; Borsali R; Lemos-Senna E
J Pharm Sci; 2014 Nov; 103(11):3764-3771. PubMed ID: 25187001
[TBL] [Abstract][Full Text] [Related]
6. The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery.
Du H; Liu M; Yang X; Zhai G
Drug Discov Today; 2015 Aug; 20(8):1004-11. PubMed ID: 25769687
[TBL] [Abstract][Full Text] [Related]
7. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based drug delivery systems.
Bernkop-Schnürch A; Dünnhaupt S
Eur J Pharm Biopharm; 2012 Aug; 81(3):463-9. PubMed ID: 22561955
[TBL] [Abstract][Full Text] [Related]
10. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
Wang LY; Gu YH; Su ZG; Ma GH
Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
[TBL] [Abstract][Full Text] [Related]
11. A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen.
Varma S; Sadasivan C
Biomed Pharmacother; 2014 Mar; 68(2):225-30. PubMed ID: 24051124
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and controlled release of mitomycin C from a chitosan-based polymeric prodrug.
Duan L; Zheng Q; Li X; Quan D; Ge J
J Control Release; 2011 Nov; 152 Suppl 1():e18-20. PubMed ID: 22195837
[No Abstract] [Full Text] [Related]
13. Studies on drug-polymer interaction, in vitro release and cytotoxicity from chitosan particles excipient.
Gomathi T; Govindarajan C; Rose H R MH; Sudha PN; Imran PK; Venkatesan J; Kim SK
Int J Pharm; 2014 Jul; 468(1-2):214-22. PubMed ID: 24742716
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of oxidized glycerol monooleate-chitosan polymer and its hydrogel formation for sustained release of trimetazidine hydrochloride.
Zhang J; Fu M; Zhang M; Xu L; Gao Y
Int J Pharm; 2014 Apr; 465(1-2):32-41. PubMed ID: 24508554
[TBL] [Abstract][Full Text] [Related]
15. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
Rabišková M; Bautzová T; Gajdziok J; Dvořáčková K; Lamprecht A; Pellequer Y; Spilková J
Int J Pharm; 2012 Jan; 422(1-2):151-9. PubMed ID: 22079717
[TBL] [Abstract][Full Text] [Related]
16. Development of coated beads for oral controlled delivery of cefaclor: In vitro evaluation.
Rasool BK; Fahmy SA
Acta Pharm; 2013 Mar; 63(1):31-44. PubMed ID: 23482311
[TBL] [Abstract][Full Text] [Related]
17. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
[TBL] [Abstract][Full Text] [Related]
18. Polymer blends for controlled release coatings.
Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2008 Jan; 125(1):1-15. PubMed ID: 18022722
[TBL] [Abstract][Full Text] [Related]
19. Effect of chitosan coating on the swelling and controlled release of a poorly water-soluble drug from an amphiphilic and pH-sensitive hydrogel.
Colinet I; Dulong V; Mocanu G; Picton L; Le Cerf D
Int J Biol Macromol; 2010 Aug; 47(2):120-5. PubMed ID: 20471413
[TBL] [Abstract][Full Text] [Related]
20. Immersion coating of pellets with calcium pectinate and chitosan.
Hiorth M; Versland T; Heikkilä J; Tho I; Sande SA
Int J Pharm; 2006 Feb; 308(1-2):25-32. PubMed ID: 16326054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
